Harper Molly sold CPRX
June 3, 2024 · Form 4 insider transaction
Harper Molly sold 5,333 shares of Catalyst Pharmaceuticals Inc at $16.30 per share, a transaction worth $86.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,333
Price
$16.30
Total value
$86.9K
InsiderHarper Molly
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeS: Open-market sale
Transaction dateJune 3, 2024
Filing dateJune 5, 2024
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Harper remains a director of the Company.; Represents a weighted average price for the shares sold. Shares were sold in a range between $16.26 and $16.34 per share.